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ABSTRACT 
Recruitment of African Americans into research is important so that the results of clinical 
trials apply to the United States population as a whole.  There are a number of reasons that have 
been shown to affect the level of African American participation in research, such as distrust, 
lack of health care access, investigator barriers, and the disproportionate prevalence of 
comorbidities that exclude many minorities from participating in existing protocols. The object 
of this research was to determine if previous experience with the medical system, as measured by 
an assessment of the perceived quality of care, is associated with African American expressed 
willingness to participate in medical research. A questionnaire was administered in person to 117 
African Americans in the North Carolina counties of Durham, Wake, Orange, and Chatham , to 
assess this, and to collect other information regarding their expressed willingness to participate in 
research.  Results indicate that there was only a weak correlation between the perceived quality 
of care across the various types of trials, but there was an increase in the expressed willingness of 
participation in research trials when participants considered it in relation to the possibility of a 
family member being diagnosed with a deadly disease.The limitations and implications of the 
survey’s findings are discussed. 
  
INTRODUCTION 
Recruiting participants for medical research can be challenging and remains one of the 
chief hindrances in the research and development pipeline. This is especially true for research 
involving minorities.
1
  Even though the National Institutes of Health (NIH) has mandated that 
federally funded research includes minorities and women, participation rates continue to be low.
2
  
There are several reasons why there needs to be increased participation of minorities in research. 
We live in a country marked by wide diversity, and a low participation rate by minorities 
ultimately affects the generalizability of the results of these studies to the United States 
population as a whole. In addition, with increased participation of minorities, the sample sizes 
could be large enough so that subgroup analysis shows effects that are present to a greater or 
lesser extent in a particular minority. In this era of personalized medicine it would be 
advantageous to include a representative proportion of minorities to see if they have altered 
responses to treatments based on genetic differences.  Regarding drug trials, increasing 
participation of minorities could lead to more specific information in drug labels on efficacy 
and/or side effects related to race or ethnicity. Potentially, this could increase the marketability of 
drugs and increase the return on investment. On the other hand, low levels of minority 
participation, could result in unknown serious adverse events, less use of approved drugs, and 
persistent health disparities. In light of health care reform and the importance of addressing 
health care disparities, there is an urgent need to increase the participation of minorities in 
medical research. 
It has been noted that the participation rate of African Americans is low in a variety of 
studies across a wide range of therapeutic areas, such as AIDS, Alzheimer’s disease and 
cardiovascular disease.
3 
There are a number of reasons that have been shown to affect the 
participation of African Americans in research.  Much of this information is available from 
systematic reviews,
 4, 5
 focus groups 
1,6,7,8 
and surveys. 
9,1,11,12
  Some have divided the reasons for 
low participation of minorities into participant and investigator barriers.
4
 Participant barriers 
include distrust, health care access and utilization, quality of care, and cultural differences. 
Among the investigator barriers are pre-existing beliefs related to recruitment and retention of 
African Americans in trials, the perceived additional cost and effort of minority recruitment, and 
and relationships with minority health care professionals.
4
 
Distrust is related to the past history of slavery, discrimination, racism, and the history of 
the abuse of African Americans in research.
3, 4, 13
  The most notable study that continues to be 
cited today as a cause of distrust is the Tuskegee syphilis study (1932-1972). This was an 
especially protracted clinical study that was designed to study the natural course of syphilis in 
African Americans. Despite the availability of penicillin in 1947 as an effective treatment for 
syphilis, it was not made available to those in the study.  
The fact that there continues to be limited cultural diversity among physicians, and that 
minority patients receive less empathy and attention from their physicians, also add to this 
distrust.
3
 Furthermore, there is common concern that participation in a trial may not benefit the 
African American community.
3
 This distrust of medical research makes participation by African 
Americans less likely.
9
  
Limited health care access and use of medical services can also limit African-American 
participation in research. Since they may not receive primary care preventive services, minority 
patients often present at later stages of their disease with fewer treatment options, including 
research protocols available to them. In addition, minorities are often disqualified for 
participation in studies due to comorbid conditions. This is a common occurrence in the realm of 
health disparities, which reflects poorly on protocol design which often fails to take this into 
account. Lack of a primary care provider may also lead minorities to seek care at the emergency 
room—often as a last resort—where the physician may not neither aware of current trials nor 
committed to referring the patient for a clinical trial.
4 
  
 Investigator barriers
4
 can also hinder African American participation in research since 
researchers may presume  this population to be less likely to adhere to the study protocol and 
more likely to drop out and be lost to follow up. Researchers may also avoid recruiting African 
Americans, under the impression that it is burdensome and may increase their recruitment costs. 
Part of this reluctance may be related to investigators’ limited knowledge of where and when 
African Americans can best be recruited into studies.
8
 In addition, the low number of minority 
investigators, and a lack of referral relationships between researchers and those that provide care 
to minorities can also result is less recruitment into studies.
4
 It is possible that relationships with 
participants may be more easily fostered with more minority health care professionals in clinical 
investigator roles.
 
Regarding quality of care, there are numerous examples of instances when African 
Americans have not received equal treatment in health care.
4,13
 This unequal treatment can 
include such things as less access to care or use of fewer health care resources.
14
 Even patient-
physician racial concordance has been shown to be related to the perceived quality and use of 
health care.
14,15
  In addition, utilization of health care services has been shown to be associated 
with higher perceived quality of health care.
16
 It has also been suggested that one’s awareness of 
unequal treatment in health care could affect one’s decision to participate in clinical trials.4  
What has not been determined is whether previous experience with the medical system 
affects the likelihood of African Americans participating in clinical trials. The object of this 
research is to determine if previous experience with the medical system, as measured by an 
assessment of the perceived quality of care, is associated with willingness among African 
Americans to participate in medical research. The specific types of clinical trials discussed in this 
study survey include treatment trials, prevention trials, diagnostic trials and screening trials. The 
benefit of this research is that it may aid researchers in the development of strategies to recruit 
and retain more African Americans in future medical research, and may spur additional dialogue 
and positive efforts among investigators. 
METHODS 
A questionnaire was constructed that included nine questions on the perceived quality of 
care and eight questions on clinical trials. The questions on perceived quality of care all related 
to the interaction of the patient with their doctor/health care provider. Some of the questions 
relating to perceived quality of care were adapted from previous research.
14, 17
  The questions on 
clinical trials were based on the types of trials that are categorized in the search engine at 
Clinical Trials.gov.
18
 Additional questions on the questionnaire related to gender and age, three 
questions on race concordance and trust, a question on previous participation in research, and an 
open ended question on what might convince the respondent to participate in a research trial.  
The questionnaire was initially administered at shopping malls.  This was done in one to 
two hour sessions from February 3
rd
 to February 18
th
 2012. The interviewer approached people 
who appeared to be African American, based on facial characteristics and skin color. In addition, 
the interviewer preferentially approached those not involved in conversations or other activities 
such as eating or texting. If the subject agreed to the interview, they were given a cover sheet, 
which explained the purpose of the research and included those items found on a standard 
consent form. If the potential interviewee did not classify themselves as African American, or 
were not in one of the four age groups mentioned on the questionnaire, the interview was 
terminated. The interviewer then explained the survey to the participant, including a description 
of the response rating scale, which was a nine point Likert type scale. The interviewees were 
given the option to stop their participation in the survey at any point; no participants availed 
themselves of this option.   
After 50 questionnaires were completed, they were grouped by gender and age group. 
Based on the underrepresentation of certain age groups, the interviewer then went to senior 
centers to get more participation in the senior age groups. Five respondents were referred by 
friends, and their answers to the questionnaire were obtained by phone. The interviewer did go   
in to two African American beauty salons, but did not find any clients waiting who were willing 
to be interviewed. Responses on the questionnaires were collected until March 7
th
, 2012. Overall 
participants were interviewed at four shopping malls and four senior centers in four counties in 
North Carolina. Approximately 40% of those approached agreed to be interviewed. 
Statistical analysis 
Expressed willingness to participate in research was used as the dependent variable and 
was measured on a nine point scale ranging from one (for extremely unlikely) to nine (for 
extremely likely). Four types of trials were included: screening, diagnostic, treatment, and 
prevention. After responding to these four possible scenarios, the interviewer then asked these 
questions again, but this time asked the interviewees to imagine that they or a family member 
had been diagnosed with a deadly disease. This theoretical context was injected into the 
questioning to see if this would change their expressed likelihood of participation in clinical 
research.  
A nine-point Likert scale was used for two reasons: the identical response scales makes it 
easier to complete since the participants can get familiar with the choices given, and it is easier to 
format the questionnaire. In addition, it increases the precision of the measurement since 
satisfaction is measured on a continuum.
19
 
 Perceived quality of care was used as the independent variable and was measured on a 
nine point scale ranging from completely dissatisfied to completely satisfied. The items 
measuring perceived quality of care included the satisfaction with the following measures as it 
related to the respondents’ doctor/health care provider:  
 ability to be seen 
 amount of time the health care provider spends with patient 
 help in understanding their condition 
 being treated with respect 
 tendency to trust the diagnosis or conclusions 
 explanation of treatment options, 
 concern with understanding treatment options,  
 being involved in decision making 
 provider's understanding of life factors that can impact patient health and ability to follow 
treatment recommendations.  
Descriptive statistics and means were calculated for each item on the questionnaire. Pearson’s 
correlation was used to determine if there was a relationship between the perceived quality of 
care and the willingness of African Americans to participate in medical research. A two sample 
T test assuming unequal variances was used to determine if there was a significant difference in 
expressed willingness to participate in medical research when participants based their answers on 
finding out that they or a family member had been diagnosed with a deadly disease. 
RESULTS 
A total of 115 African Americans completed the entire interviewer administered 
questionnaire/survey. Two participants completed only part of the questionnaire due to an 
unforeseen interruption. The age and gender breakdown is shown in Table 1. There was stronger 
female representation (55%), and the highest number of responses was in the 18-30 year old age 
category (35.9%). The level of satisfaction with perceived quality of care items are given in 
Table 2. The highest mean score was for satisfaction with their health care provider treating them 
with respect (8.29) and the lowest score was found for the health care provider’s level of 
understanding of the various factors in the respondent’s life that may impact their health and 
ability to follow the medical recommendations (6.70). Regarding specific response categories, 
Table 3 shows that the majority of participants were completely satisfied with all the perceived 
quality of care items.  
Responses to the questions on expressed willingness to participate in research are in table 
4. Willingness to participate was increased for all types of trials when participants based their 
answers on finding out that they or a family member was diagnosed with a deadly disease. The 
mean difference was significant at a 99% confidence level for all four types of trials, and the 
most significant difference was for treatment trials. (p<.000000003)  
 Table 5 contains the response to the questions on race concordance. The majority of 
respondents (68.38%) rarely had a doctor of the same race more than twice. Table 6 shows that 
the majority also stated that a doctor’s race would not impact their healthcare experience 
(72.65%), nor would it impact their trust overall and whether they had confidence in what the 
doctor told them (66.67%). 
Correlation analysis (Table 7) showed that there was a very weak relationship between 
the individual perceived quality of care measures and expressed willingness to participate in all 
four types of research. The strongest relationship was between the satisfaction with the time the 
doctor spent with the subject and participation in a prevention trial (0.34) 
Regarding participation in previous research (Table 8), 29% of all respondents had 
previously participated. On a percentage basis, the greatest participation was in the 46-65 age 
group, and overall females had the highest percentage of participation. There was no significant 
difference between the likelihood of females and males participating in the four different types of 
trials that were asked about in the questionnaire (Table 9). 
There were a number of different responses given to the question, “What would have to 
happen for you, or a friend or a family member, to actually participate in a clinical trial?” (Table 
10). Most were related to having enough information about the trial, knowing the advantages and 
disadvantages, and any side effects. Money was noted by several as being able to influence their 
decision. Some said they would become involved if they or a family member were affected with 
an illness, and others said all it would take was to be asked to participate. There were a number 
of people that would not be interested under any circumstances.  
Of those that participated in previous research, many felt it was a good experience and 
that they would do it again. Specific comments were “pleasant,” “all right,” “came out OK,” and 
“educational.” Some pointed out that the trial they were in helped them to stop smoking, 
improved their blood pressure, helped their breast cancer, and one stated “I am alive today 
because I participated in the study.”  Others preferred trials that did not include medications. One 
mentioned that she was not able to continue in one trial because of a side effect of the medicine, 
and others noted that appointment time was not always convenient, or that their work schedule 
got in the way. 
DISCUSSION 
This study was undertaken to determine if previous experience with the medical system, 
as measured by an assessment of the perceived quality of care, is associated with African 
American willingness to participate in medical research. Results indicate that there was only a 
weak correlation between the satisfaction measures and the different types of trials. The strongest 
correlation was for satisfaction with the time the doctor spent with the subject and participation 
in a prevention trial.  
There are several potential explanations for this result. The instrument to measure 
perceived quality of care in this study was not validated. Unfortunately many studies measuring 
quality of care use non-standardized methods, and validity and reliability are often not 
measured.
20
  In this study, the perception of the quality of care was measured based on 
satisfaction with the health care provider, which does not necessarily signify that the patient had 
a good experience, and may not correlate very well with the actual technical quality of care 
received.
21
 In addition, a limited number of questions were used since it was felt that a 
questionnaire of greater length would take longer to complete and make it less likely that people 
would participate. As an example, the Patient Satisfaction questionnaire (PSQ) is a 55 Likert 
type items that takes an average of 11 minutes to complete, and even longer for disadvantaged 
respondents.
19
 Adding this to the time taken to respond to the other 13 questions on the 
questionnaire used in this study would not have been acceptable.  
Regarding the satisfaction measures, the fact that the highest mean score was for 
satisfaction with their health care provider treating them with respect is consistent with the high 
value placed on trust. The lowest score was for the health care providers’ level of understanding 
of the various factors in the respondent’s life that may impact their health and ability to follow 
the medical recommendations. This may be due to the fact that providers focus on diagnosing 
and treating an illness, and have less concern for factors in the patient’s personal life. It is 
important for health care providers to consider issues such as patient’s time, ability to pay for 
medications and social support in order to encourage adherence to the treatment regimen. 
22
 
As for the different types of trials investigated, the finding that the willingness of 
participating in treatment trials was less than other types of trials is consistent with findings from 
focus group research showing that African Americans are more likely to participate in non-
invasive research, being more likely to give fluid samples but less likely to want to receive an 
injection.
7
 The increase in willingness of participation in research when participants based their 
answers on finding out that they or a family member were diagnosed with a deadly disease, is 
also in agreement with other authors’ findings showing that those with a medical illness or who 
are close to someone who is ill are more likely to participate in research trial.
11
 As an example, 
focus group research has shown that some people participate in research to reduce their risk of 
another stroke.
12
   
Although the majority of participants reported that they rarely had a doctor of the same 
race as they, the question asked how often this occurred (and not if it was the present situation). 
In addition, the categories for the responses were not equally weighted. Therefore no attempt was 
made to try to correlate this finding with their perceived quality of care or likelihood of 
participating in research. The finding in this study that the majority of respondents stated that a 
doctor’s race would not impact their healthcare experience nor would it impact their trust overall 
and whether they had confidence in what the doctor told them, is in contrast to findings in the 
literature that show that blacks were more satisfied when they received care from black versus 
nonblack physicians.
14, 15 
 The person administering the questionnaire in this study was white, 
and it is not known if, or to what extent, this racial discordance might have affected responses. In 
addition, the articles cited here used data from the Commonwealth Fund Minority Health Survey, 
which was a telephone survey and not done in person. Furthermore, the findings are based on 
information collected in 1994, and may not be representative of today’s situation. Therefore, this 
is an area that is worthy of future research 
 The responses to the question, “What would have to happen for you, or a friend or a 
family member, to actually participate in a clinical trial?” did not reveal any new reasons that 
have not been previously noted in the literature, and the reason given most commonly was 
something concerning their health or to help a family member. Other reasons were knowing 
more about the advantages and disadvantages of the trial, and trust. These could be addressed by 
better pre-consent education.
23
 In addition, ten respondents said they would participate if 
someone just asked, which suggests that increasing awareness of clinical trials in the African 
American population could increase participation.
11
 It was encouraging to find that all of those 
that had been in a clinical trial found it to be a good experience, which could certainly increase 
their participation in future trials.
11
 In fact, in populations previously exposed to research, 
African Americans were as likely as whites to participate, and specifically there was a higher 
odds of participating in a diet trial.
24
 
There are a number of limitations in this study. A convenience sample was used so the 
generalizability of the study is limited. In addition the sample is overrepresented by the 18 to 30 
year old cohort. In this study, the author approached people of all ages but was not able to tell the 
age of those that refused to participate. There may be better locations to obtain participants in all 
the different age groups. Future research could deliver the survey on line in a random fashion to 
increase the generalizability of the study results. 
Selection bias is also an issue since the interviewer did not collect any information on 
those that refused to participate in the interview in order to evaluate any differences between 
participants and non-participants. In addition, those that chose to participate may have done so 
because they have been overall satisfied with their health care or were already interested in 
participating in clinical trials. This would skew the results in a positive direction. Another 
limitation is that the participants’ opinions were asked regarding hypothetical trials, and their 
decision to participate in an actual trial is unknown. 
Interviewer bias is possible in interviewer administered questionnaires, and could be due 
to the interviewer not being neutral and suggesting responses, or the interviewee who may not 
wish to reveal beliefs not endorsed by the interviewer.
25
 Again, the discordance of race between 
interviewer and interviewee may have played into the responses, and perceptions of interviewees 
about the white interviewer’s beliefs may have held sway. It is also possible that some of those 
that chose not to be interviewed did so because the interviewer was not the same race as them. In 
this study, the interviewer tried to remain neutral, and when people would respond with answers 
such as “all right,”, “good,” or “great”, he would ask them to give their rating on the one to nine 
scale. In future studies, having two identical interviews conducted by separate interviewers—one 
African American and one white—might offer additional insights as to whether the race of the 
interviewer makes any measureable difference in responses. 
CONCLUSION 
In order to decrease disparities in health care, it is important that all minorities, including African 
Americans, participate in clinical research. Various factors such as distrust, lack of health care 
access, and the disproportionate prevalence of comorbidities that exclude many minorities from 
participating in research trials have been studied. In this research, an attempt was made to  
determine if previous experience with the medical system, as measured by an assessment of the 
perceived quality of care, is associated with African American willingness to participate in 
medical research. Although there was no significant correlation found in this study between the 
perceived quality of care and the expressed willingness of African-Americans participating in 
clinical trials, there was an increased in expressed willingness to participate in research when 
participants based their answers on finding out that they or a family member were diagnosed 
with a deadly disease. This finding could serve as motivation for African Americans to 
participate in studies.  Considering that there continue to be barriers to participation in research 
by African Americans, it is important to explore any avenues to increasing participation, from 
both a scientific as well as a social justice view. The study demonstrates the need for future 
research into the factors that influence African American participation in research.  
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Table 1. Demographic makeup of respondents (n=117) 
Age Group  Female Male  Percent of total 
18-30   21  21   35.9 
31-45   13  11   20.51 
46-65   14  11   21.37 
66-88   16  10   22.22 
Total   64(55%) 53 (45%)  100.00 
 
  
Table 2. Perceived quality of care (n=117) 
On a scale from 1-completely dissatisfied to 9-completely satisfied, how satisfied are you with 
your doctor/health care provider in the following areas:_________________________________ 
       Mean  standard deviation 
Ability to be seen     7.58   1.50 
Amount of time spent with you   7.49   1.53 
Helping you to understand your condition  7.75   1.27 
Treating you with respect    8.29   1.01 
Trusting the diagnosis     7.56   1.37 
Explaining your treatment options   7.62   1.46 
Concern regarding your understanding  7.36   1.63 
Involving you in decision making   7.17   1.90 
Consideration impactful life factors   6.70   2.11 
 
 
 
 
 
 
 
 
 
 
Table 3. Perceived quality of care (n=117) 
On a scale from 1-completely dissatisfied to 9-completely satisfied, how satisfied are you with your doctor/health care provider in the 
following areas:______________________________________________________________________________________________ 
 
1     2 3 4     5     6      7     8 9 
Ability to be seen 2.56% 1.71% 2.56% 0.00% 5.13% 7.69% 19.66% 11.11% 49.57% 
Amount of time spent with you 2.56% 0.85% 3.42% 2.56% 5.13% 6.84% 17.09% 16.24% 45.30% 
Helping you to understand your 
condition 1.71% 0.85% 0.00% 1.71% 5.98% 7.69% 14.53% 20.51% 47.01% 
Treating you with respect 0.00% 1.71% 2.56% 0.00% 1.71% 4.27%    5.13% 13.68% 70.94% 
Trusting the diagnosis 0.85% 1.71% 0.00% 3.42% 6.84% 8.55% 17.95% 18.80% 41.88% 
Explaining your treatment options 0.85% 2.56% 2.56% 2.56% 5.13% 5.13% 16.24% 17.09% 47.86% 
Concern regarding your understanding 3.42% 0.85% 4.27% 3.42% 4.27% 6.84% 15.38% 19.66% 41.88% 
Involving you in decision making 5.98% 2.56% 2.56% 4.27% 5.98% 4.27% 15.38% 12.82% 46.15% 
Consideration impactful life factors 5.13% 4.27% 5.13% 5.13% 10.26% 8.55%    7.69% 20.51% 33.33% 
 
 Table 4. Comparison of expressed willingness to participate in research  
    Mean  Mean  Difference P value *  
    before
a
  after
b
                                                                                   
    (n=116) (n=115) 
Screening trial   6.93  8.02  1.09  0.0004 
Diagnostic trial  6.91  8.04  1.13  0.0002 
Treatment trial  3.94  6.50  2.56  0.000000003 
Prevention trial  7.71  8.33  0.62  0.02 
____________________________________________________________________________ 
a
Response to question before asking about deadly illness                                                  
b
Response to question after asking about deadly illness                                                                   
* P values are based on paired t tests.                                                                                                                                       
 
  
Table 5. Race concordance (n=117)________________________________________________ 
Categories    N  % 
Never     27  23.08 
Once or twice    53  45.30 
Between three and five times  18  15.38 
More than five but less than ten   8    6.84 
More than ten but less than 15X 10    8.55 
Always       1    0.85  
 
 
Table 6. Impact of race (n=117)___________________________________________________ 
Overall healthcare experience      On trust overall__________ 
Categories  N      %    N      % 
1  0    0    1    0.85   
2  0    0    0    0 
3  2    1.71    0    0 
4  1    0.85    1    0.85 
5  85  72.65    78  66.67 
6  6    5.13    6    5.13 
7  6    5.13    10    8.55 
8  10    8.55    13  11.11 
9  7    5.98      8    6.84 
 
 
 
 Table7. Corelation of perceived quality of care to expressed willingness to participate in 
research 
 
      ST  DT  TT  PT 
Ability to be seen    -0.007  -0.019  -0.110  0.126 
     
Amount of time spent with you  0.098  0.154  0.025  0.340 
  
Helping you to understand condition  0.110  0.111  0.004  0.181  
 
Treating you with respect   0.015  -0.056  0.017  0.155 
     
Trusting the diagnosis    0.218  0.171  0.178  0.246 
    
Explaining your treatment options  0.165  0.182  0.039  0.233  
 
Concern regarding your understanding 0.086  0.038  0.011  0.179 
  
Involving you in decision making  0.079  0.174  0.039  0.206 
    
Consideration impactful life factors  1.041  0.060  0.120  0.233  
______________________________________________________________________________ 
ST=Screening trial; DT= Diagnostic trial; TT= Treatment trial; PT= Prevention trial   
Table 8 .Previous participation in research (n=115)__________________________________  
    Female         Male_____________ 
Age Group  Participate Not participate Participate Not participate 
   N % N %  N % N % 
18-30   6  29 15 71  3 14 17 86  
31-45   3 23 10 77  1 9 10 91 
46-65   7 50 7 50  4 36 7 64 
66-88   5 31 10 69  4 25 6 75 
All   21 18 42 36  12 11 40 35 
 
Table 9. Mean difference in expressed willingness to participate in research male vs female 
(n=116 
    Female  Male   p 
Screening trial   6.98   6.87   0.82      
Diagnostic trial  6.82   7.02   0.69   
Treatment trial  4.01   3.85   0.77   
Prevention trial  7.52   7.94   0.30 
 
 
 
 
 
 
 
 
 
Table 10.  Reasons for participating in research trials (n=115)  
        Count 
Something concerning their health    11 
If it could help a family member    12 
Feeling secure about advantages and disadvantages  13 
If someone asks      10 
Type of trial       9 
Time required       8 
Money        5 
Need to be convinced      2 
Trust in researched      1 
 
 
 
 
